These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35056984)

  • 1. Novel Selectively Targeted Multifunctional Nanostructured Lipid Carriers for Prostate Cancer Treatment.
    Cohen L; Assaraf YG; Livney YD
    Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEG-PLA nanoparticles decorated with small-molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells.
    Afsharzadeh M; Hashemi M; Babaei M; Abnous K; Ramezani M
    J Cell Physiol; 2020 May; 235(5):4618-4630. PubMed ID: 31674023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A ROS-responsive polymeric prodrug nanosystem with self-amplified drug release for PSMA (-) prostate cancer specific therapy.
    Wang Y; Zhang Y; Ru Z; Song W; Chen L; Ma H; Sun L
    J Nanobiotechnology; 2019 Aug; 17(1):91. PubMed ID: 31451114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted nanomedicine modalities for prostate cancer treatment.
    Cohen L; Livney YD; Assaraf YG
    Drug Resist Updat; 2021 May; 56():100762. PubMed ID: 33857756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plumbagin-loaded aptamer-targeted poly D,L-lactic-co-glycolic acid-b-polyethylene glycol nanoparticles for prostate cancer therapy.
    Pan M; Li W; Yang J; Li Z; Zhao J; Xiao Y; Xing Y; Zhang X; Ju W
    Medicine (Baltimore); 2017 Jul; 96(30):e7405. PubMed ID: 28746182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dually targeted bioinspired nanovesicle delays advanced prostate cancer tumour growth in vivo.
    Ma G; Severic M; Barker M; Pereira S; Ruiz A; Cheung CCL; Al-Jamal WT
    Acta Biomater; 2021 Oct; 134():559-575. PubMed ID: 34274531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti prostate cancer using PEGylated bombesin containing, cabazitaxel loading nano-sized drug delivery system.
    Chen W; Guo M; Wang S
    Drug Dev Ind Pharm; 2016 Dec; 42(12):1968-1976. PubMed ID: 27143168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles.
    Chen Y; Deng Y; Zhu C; Xiang C
    Biomed Pharmacother; 2020 Jul; 127():110181. PubMed ID: 32416561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of 5D3-DM1: A Novel Anti-Prostate-Specific Membrane Antigen Antibody-Drug Conjugate for PSMA-Positive Prostate Cancer Therapy.
    Huang CT; Guo X; Bařinka C; Lupold SE; Pomper MG; Gabrielson K; Raman V; Artemov D; Hapuarachchige S
    Mol Pharm; 2020 Sep; 17(9):3392-3402. PubMed ID: 32803984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells.
    Kim CH; Kang TH; Kim BD; Lee TH; Yoon HY; Goo YT; Choi YS; Kang MJ; Choi YW
    Int J Pharm; 2020 Jun; 583():119393. PubMed ID: 32376445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer.
    Nagesh PKB; Johnson NR; Boya VKN; Chowdhury P; Othman SF; Khalilzad-Sharghi V; Hafeez BB; Ganju A; Khan S; Behrman SW; Zafar N; Chauhan SC; Jaggi M; Yallapu MM
    Colloids Surf B Biointerfaces; 2016 Aug; 144():8-20. PubMed ID: 27058278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
    Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.
    Dhar S; Gu FX; Langer R; Farokhzad OC; Lippard SJ
    Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17356-61. PubMed ID: 18978032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Nanoparticles Harboring Jasmine-Oil-Entrapped Paclitaxel for Elimination of Lung Cancer Cells.
    Engelberg S; Lin Y; Assaraf YG; Livney YD
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release.
    Li Y; Wu H; Yang X; Jia M; Li Y; Huang Y; Lin J; Wu S; Hou Z
    Mol Pharm; 2014 Aug; 11(8):2915-27. PubMed ID: 24984984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
    Lin M; Teng L; Wang Y; Zhang J; Sun X
    Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy.
    Chen Z; Tai Z; Gu F; Hu C; Zhu Q; Gao S
    Eur J Pharm Biopharm; 2016 Oct; 107():130-41. PubMed ID: 27393562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-responsive polymeric micelles of cabazitaxel for prostate cancer targeted therapy.
    Barve A; Jain A; Liu H; Zhao Z; Cheng K
    Acta Biomater; 2020 Sep; 113():501-511. PubMed ID: 32562805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacious delivery of protein drugs to prostate cancer cells by PSMA-targeted pH-responsive chimaeric polymersomes.
    Li X; Yang W; Zou Y; Meng F; Deng C; Zhong Z
    J Control Release; 2015 Dec; 220(Pt B):704-14. PubMed ID: 26348387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system.
    Zhang S; Lu C; Zhang X; Li J; Jiang H
    Drug Deliv; 2016 Jun; 23(5):1838-45. PubMed ID: 26879035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.